SCHEMBL4145134

SCHEMBL4145134

Cc1cc(SC(F)F)ccc1N(C)C(=O)NC(=O)c1c(F)cccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.43
RAB9A P51151 5/20 0.39
NPC1 O15118 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
RORC P51449 1/20 0.36
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP3 P42574 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
GAA P10253 3/20 0.32
POLB P06746 1/20 0.32
TRPA1 O75762 1/20 0.32
STIM1 Q13586 1/20 0.32
ORAI1 Q96D31 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148300 0.91 ATM (0.45) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL4637022 0.88 NPC1 (0.41) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL4142542 0.88 ATM (0.42) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL4146966 0.85 ATM (0.34) ATMRORCMAPTMEN1KMT2A
SCHEMBL4150857 0.84 RORC (0.36) RAB9ASMN1; SMN2RORCMAPTLMNA
SCHEMBL4157938 0.83 RORC (0.35) ATMRAB9ARORCMAPTMEN1
SCHEMBL4150090 0.81 ATM (0.49) ATMRAB9ANPC1SMN1; SMN2MEN1
SCHEMBL4158469 0.81 RORC (0.38) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL4154199 0.78 RAB9A (0.38) ATMRAB9ANPC1SMN1; SMN2RORC
SCHEMBL5314175 0.77 ATM (0.40) ATMRAB9ANPC1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 ATM 2385/4885RAB9A 642/4885NPC1 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.